CIPLOX

This brand name is authorized in Ecuador, Ireland, Malta

Active ingredients

The drug CIPLOX contains one active pharmaceutical ingredient (API):

1 Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. Read about Ciprofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CIPLOX Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29243-05-10
Country: IE	Health Products Regulatory Authority	Identifier(s): 18964, 18966, 18968, 18970, 18972
Country: MT	Medicines Authority	Identifier(s): AA1330/01001, AA770/16001, AA770/16002